Changes

Jump to: navigation, search

Argatroban (Acova)

225 bytes added, 19:43, 26 April 2017
no edit summary
==General information==
Class/mechanism: Direct thrombin inhibitor, binds reversibly to free and clot-associated thrombin and inhibits its effects of catalyzing the formation of fibrin from fibrinogen, platelet aggregation, activation of protein C, and activation of coagulation factors V, VIII, and XIII.<ref name="insert">[https://www.gsksource.com/gskprmpharma/htdocscontent/documentsdam/GlaxoSmithKline/US/en/Prescribing_Information/Argatroban/pdf/ARGATROBAN.PDF Argatroban package insert]</ref><ref>[[Media:Argatroban.pdf | Argatroban package insert (locally hosted backup)]]</ref><ref>[httphttps://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=ProductDetailPage&product_id=1244136535577 argatroban Argatroban manufacturer's website]</ref>
<br>Route: IV
<br>Extravasation: no information
==Patient drug information==
*Brief patient counseling information can be found in the [https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Argatroban/pdf/ARGATROBAN.PDF Argatroban package insert]<ref name="insert"></ref>
*[http://www.uptodate.com/contents/argatroban-patient-drug-information Argatroban patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/argatroban-patient-drug-information Argatroban patient drug information (UpToDate)]</ref>
LookupUsers, editors, emailconfirmed
3,827
edits

Navigation menu